Canada-based ExCellThera Inc., a global leader in blood stem cell expansion and metabolic fitness technologies and paren...
The Hong Kong University of Science and Technology (HKUST) and the Ministry of Higher Education, Science, and Technology...
Lynk Pharmaceuticals has completed patient enrolment in its Phase III clinical trial of zemprocitinib capsules for activ...
Kelun-Biotech has reported positive Phase III results for sacituzumab tirumotecan, also known as sac-TMT or SKB264/MK-28...
Lynk Pharmaceuticals has dosed the first patient in a Phase II clinical trial of LNK01004 ointment for vitiligo. The tr...
Delonix Bioworks has dosed the first participant in its Phase 1 clinical trial of DX-104, a next-generation Group B meni...
China-based startup OTR Therapeutics has entered into a strategic collaboration agreement with Korean company LG Chem to...
The School of Optometry at The Hong Kong Polytechnic University (PolyU) and HOYA Vision Care have long been committed to...
Insilico Medicine has initiated a Phase III clinical trial of rentosertib, its AI-discovered oral small-molecule TNIK in...
Taiwan-based HanchorBio, Inc. is taking another step to broaden the development path for HCB101, its lead oncology asset...
Brii Biosciences has reported topline end-of-treatment data from its ongoing Phase 2b ENRICH and ENHANCE studies evaluat...
UniXell Biotechnology has received U.S. FDA Investigational New Drug clearance for UX-DA003, its allogeneic induced plur...
Hong Kong-based Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, has announced a strategi...
China-based Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have jointly announced the offi...
China-based CanSino Biologics Inc. has announced that the company's ACYW135 Meningococcal Polysaccharide Conjugate Vacci...
The International Health Innovation & Exchange Association (IHIEA) recently held its launch press conference in Hong...
China-based ATLATL Innovation Center, a global innovation platform for life science research and development, and Korea'...
Innovent Biologics has dosed the first patient in the Chinese pivotal Phase III TriadicMM-1 trial of IBI3003 for relapse...
China-based Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with US-based...
Sankara Eye Hospital, India and The Chinese University of Hong Kong (CUHK) recently signed a landmark Memorandum of...
SystImmune and parent company Sichuan Biokin Pharmaceutical have received regulatory approval in China for iza-bren, als...
China-based CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that as...
Chime Biologics, a global biologics contract development and manufacturing organisation (CDMO), has announced the inaugu...
Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO) for biotechs, today announced ...
WuXi Biologics’ Suzhou Biosafety Testing Center has passed a European Medicines Agency Good Manufacturing Practice...
